The MV Hondius Andes virus cluster is approaching its formal end. As of early June 2026, all 17 confirmed cases have been discharged from hospital, no new linked cases have appeared since May 19, ECDC has downgraded the cluster from HIGH to LOW risk, and the vessel itself is nearing completion of a mandatory biosafety refit in Rotterdam.
This article documents how the Hondius outbreak was contained, what the contact monitoring found, and which changes to expedition vessel biosafety are now permanent.
Final Case Count
| Metric | Value |
|---|---|
| Total confirmed cases | 17 |
| Deaths | 3 (CFR ~18%) |
| Countries with cases | 11 |
| Confirmed P2P events | 2 (France) |
| Last new case confirmed | May 19, 2026 |
| Days without new case (as of June 6) | 18 |
| ECDC risk classification | LOW (as of June 6) |
The cluster’s CFR of approximately 18% is well below the expected Andes HPS baseline of 35–40%, attributed primarily to early ICU escalation and ECMO access at major European academic centers.
How the Monitoring Resolved
France had the most complex surveillance task following the two confirmed household P2P events. All French secondary cases have been discharged, and comprehensive tertiary contact tracing found zero onward transmission. ECDC regards France’s two P2P clusters as closed with full genomic confirmation of the transmission chains.
Netherlands maintained the most cases after Argentina: 8 confirmed Hondius-linked patients. RIVM cleared all Dutch monitoring cohorts through late May and early June without additional positives.
Germany confirmed the final contact-linked case on May 15. All subsequent German monitoring files closed without positives.
Belgium, Switzerland, Italy, UK, Canada, New Zealand, and Ireland each had one or two cases that were managed and resolved without secondary transmission.
ECDC’s formal downgrade timeline:
- May 28: HIGH → MODERATE
- June 6: MODERATE → LOW
The Pre-Symptomatic Andes RNA Finding
One of the cluster’s most scientifically significant outputs was ECDC’s May 18 finding of Andes virus RNA in nasal secretions 48–72 hours before symptom onset in at least two patients. This was the first published evidence of a pre-symptomatic infectious window for Andes virus in an outbreak context.
It prompted ECDC to formally extend the contact tracing exposure window from symptom onset to 14 days before symptom onset — a substantial expansion that drove the broader monitoring scope seen across European countries.
The finding will inform Andes virus response guidance globally and is expected to feature prominently in the WHO-IMO maritime biosafety code.
Permanent Changes: What the Hondius Outbreak Made Mandatory
1. WHO-IMO Antarctic Expedition Vessel Biosafety Code
The Hondius outbreak directly triggered the WHO-IMO joint taskforce, whose first working draft of a comprehensive Antarctic expedition vessel biosafety code is due June 20, 2026. Key provisions expected:
- Mandatory onboard PCR capacity for Andes virus and other relevant pathogens on expedition vessels operating in endemic zones
- Minimum two isolation cabins with negative-pressure capability
- Rodent exclusion protocols at Patagonian provisioning ports
- Crew health certification for biosafety response, renewed annually
- Pre-embarkation health screening for all passengers on Antarctic routes
- SOLAS and ISM Code integration for flag-state enforcement
2. IAATO Interim Rules (Already in Force)
IAATO adopted interim biosafety rules effective June 1, 2026, ahead of the WHO-IMO code’s finalization. All IAATO member operators are now required to document isolation pathways, enhanced screening, and staff training while the formal code is developed.
3. ECDC Pre-Symptomatic Contact Window (Now EU Standard)
The formalized 14-day pre-symptom tracing window for Andes virus contacts is now the EU/EEA standard, embedded in ECDC’s updated rapid risk assessment and member-state guidance.
4. MV Hondius Refit (Model for Future Vessels)
The Rotterdam refit of MV Hondius — PCR laboratory, isolation cabins, ventilation adjustments, crew certification — is now the reference implementation for Antarctic expedition vessel biosafety retrofits.
What the Cluster Demonstrated About Andes Virus
-
R₀ approximately 0.5 in household settings: The outbreak was consistent with Nature Medicine’s estimate — chains remain short, which is why 17 cases across 11 countries did not grow into a multinational epidemic.
-
ECMO access is a survival determinant: European ICU capability, including rapid ECMO escalation at academic centers, measurably improved outcomes versus historical Andes HPS case series.
-
Pre-symptomatic RNA shedding is real: The pre-symptomatic window finding has implications for future outbreak response protocols worldwide.
-
Expedition settings are credible exposure routes: The Hondius cluster is the first documented large-scale expedition-associated Andes virus event, clarifying that controlled outdoor adventure tourism in endemic zones carries genuine pathogen transmission risk.
Remaining Open Questions
- Full 6-month follow-up data for survivors: Not yet available; expected through autumn 2026.
- Final WHO-IMO code text: Due June 20; adoption into SOLAS timeline uncertain.
- WHO-IAATO MV Hondius final inspection: Scheduled for approximately mid-June; outcome will determine restart eligibility.
Current data and monitoring updates: Hantavirus News
Explore HantavirusMap